Comunicati.net - Comunicati pubblicati - Tecnologia Comunicati.net - Comunicati pubblicati - Tecnologia Tue, 16 Jan 2018 20:27:37 +0100 Zend_Feed_Writer 1.11.10 (http://framework.zend.com) http://comunicati.net/comunicati/aziende/tecnologia/1 IgA Nephropathy Pipeline to Witness Various Collaborations in the Coming Years Mon, 15 Jan 2018 19:06:43 +0100 http://comunicati.net/comunicati/aziende/tecnologia/466037.html http://comunicati.net/comunicati/aziende/tecnologia/466037.html P&S research market P&S research market The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates in different stages of development. IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when IgA antibody gets settled in the kidneys. This leads to inflammation that with time hinders the kidney’s ability to filter wastes from blood.

 

IgA nephropathy is a silent disease in its early stages with no symptoms. But the most common symptoms that are usually observed are proteinuria and hematuria. IgA nephropathy does not have a specific treatment, and the only treatment available is to delay or prevent end stage renal disease (ESRD). Therefore, combination therapies are being used to slow down the rate of proteinuria and hematuria and the use of various targets including a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS) is expected to provide an effective and concrete treatment for the disease, with latest technological advancements further adding to the pipeline growth.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample

 

 

Pharmalink AB is using TARGIT drug delivery technology platform for the development of Budesonide for IgA nephropathy. The TARGIT technology is based on the application of a combination of enteric polymers onto injection-moulded starch capsules, for the targeted delivery of drugs to specific regions of the large intestine.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=iga-nephropathy-pipeline-analysis

 

The research finds that different companies have collaborated for the development of IgA nephropathy pipeline. In October 2012, Pharmalink AB entered into a contract with Patheon Inc. for manufacturing of Nefecon.

Some of the key players developing drugs for IgA nephropathy include Mallinckrodt plc, Merck KGaA, Anthera Pharmaceuticals, Inc. and others.

IgA Nephropathy Pipeline Analysis

  • By Phase
  • By Route of Administration
  • By Target
  • By Company

 

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

]]>
IgA Nephropathy Pipeline to Witness Various Collaborations in the Coming Years Mon, 15 Jan 2018 19:06:36 +0100 http://comunicati.net/comunicati/aziende/tecnologia/466036.html http://comunicati.net/comunicati/aziende/tecnologia/466036.html P&S research market P&S research market The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates in different stages of development. IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when IgA antibody gets settled in the kidneys. This leads to inflammation that with time hinders the kidney’s ability to filter wastes from blood.

 

IgA nephropathy is a silent disease in its early stages with no symptoms. But the most common symptoms that are usually observed are proteinuria and hematuria. IgA nephropathy does not have a specific treatment, and the only treatment available is to delay or prevent end stage renal disease (ESRD). Therefore, combination therapies are being used to slow down the rate of proteinuria and hematuria and the use of various targets including a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS) is expected to provide an effective and concrete treatment for the disease, with latest technological advancements further adding to the pipeline growth.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample

 

 

Pharmalink AB is using TARGIT drug delivery technology platform for the development of Budesonide for IgA nephropathy. The TARGIT technology is based on the application of a combination of enteric polymers onto injection-moulded starch capsules, for the targeted delivery of drugs to specific regions of the large intestine.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=iga-nephropathy-pipeline-analysis

 

The research finds that different companies have collaborated for the development of IgA nephropathy pipeline. In October 2012, Pharmalink AB entered into a contract with Patheon Inc. for manufacturing of Nefecon.

Some of the key players developing drugs for IgA nephropathy include Mallinckrodt plc, Merck KGaA, Anthera Pharmaceuticals, Inc. and others.

IgA Nephropathy Pipeline Analysis

  • By Phase
  • By Route of Administration
  • By Target
  • By Company

 

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

]]>
IgA Nephropathy Pipeline to Witness Various Collaborations in the Coming Years Mon, 15 Jan 2018 19:06:29 +0100 http://comunicati.net/comunicati/aziende/tecnologia/466035.html http://comunicati.net/comunicati/aziende/tecnologia/466035.html P&S research market P&S research market The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates in different stages of development. IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when IgA antibody gets settled in the kidneys. This leads to inflammation that with time hinders the kidney’s ability to filter wastes from blood.

 

IgA nephropathy is a silent disease in its early stages with no symptoms. But the most common symptoms that are usually observed are proteinuria and hematuria. IgA nephropathy does not have a specific treatment, and the only treatment available is to delay or prevent end stage renal disease (ESRD). Therefore, combination therapies are being used to slow down the rate of proteinuria and hematuria and the use of various targets including a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS) is expected to provide an effective and concrete treatment for the disease, with latest technological advancements further adding to the pipeline growth.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample

 

 

Pharmalink AB is using TARGIT drug delivery technology platform for the development of Budesonide for IgA nephropathy. The TARGIT technology is based on the application of a combination of enteric polymers onto injection-moulded starch capsules, for the targeted delivery of drugs to specific regions of the large intestine.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=iga-nephropathy-pipeline-analysis

 

The research finds that different companies have collaborated for the development of IgA nephropathy pipeline. In October 2012, Pharmalink AB entered into a contract with Patheon Inc. for manufacturing of Nefecon.

Some of the key players developing drugs for IgA nephropathy include Mallinckrodt plc, Merck KGaA, Anthera Pharmaceuticals, Inc. and others.

IgA Nephropathy Pipeline Analysis

  • By Phase
  • By Route of Administration
  • By Target
  • By Company

 

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

]]>
IgA Nephropathy Pipeline to Witness Various Collaborations in the Coming Years Mon, 15 Jan 2018 19:06:23 +0100 http://comunicati.net/comunicati/aziende/tecnologia/466034.html http://comunicati.net/comunicati/aziende/tecnologia/466034.html P&S research market P&S research market The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates in different stages of development. IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when IgA antibody gets settled in the kidneys. This leads to inflammation that with time hinders the kidney’s ability to filter wastes from blood.

 

IgA nephropathy is a silent disease in its early stages with no symptoms. But the most common symptoms that are usually observed are proteinuria and hematuria. IgA nephropathy does not have a specific treatment, and the only treatment available is to delay or prevent end stage renal disease (ESRD). Therefore, combination therapies are being used to slow down the rate of proteinuria and hematuria and the use of various targets including a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS) is expected to provide an effective and concrete treatment for the disease, with latest technological advancements further adding to the pipeline growth.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample

 

 

Pharmalink AB is using TARGIT drug delivery technology platform for the development of Budesonide for IgA nephropathy. The TARGIT technology is based on the application of a combination of enteric polymers onto injection-moulded starch capsules, for the targeted delivery of drugs to specific regions of the large intestine.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=iga-nephropathy-pipeline-analysis

 

The research finds that different companies have collaborated for the development of IgA nephropathy pipeline. In October 2012, Pharmalink AB entered into a contract with Patheon Inc. for manufacturing of Nefecon.

Some of the key players developing drugs for IgA nephropathy include Mallinckrodt plc, Merck KGaA, Anthera Pharmaceuticals, Inc. and others.

IgA Nephropathy Pipeline Analysis

  • By Phase
  • By Route of Administration
  • By Target
  • By Company

 

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

]]>
IgA Nephropathy Pipeline to Witness Various Collaborations in the Coming Years Mon, 15 Jan 2018 19:06:15 +0100 http://comunicati.net/comunicati/aziende/tecnologia/466033.html http://comunicati.net/comunicati/aziende/tecnologia/466033.html P&S research market P&S research market The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates in different stages of development. IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when IgA antibody gets settled in the kidneys. This leads to inflammation that with time hinders the kidney’s ability to filter wastes from blood.

 

IgA nephropathy is a silent disease in its early stages with no symptoms. But the most common symptoms that are usually observed are proteinuria and hematuria. IgA nephropathy does not have a specific treatment, and the only treatment available is to delay or prevent end stage renal disease (ESRD). Therefore, combination therapies are being used to slow down the rate of proteinuria and hematuria and the use of various targets including a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS) is expected to provide an effective and concrete treatment for the disease, with latest technological advancements further adding to the pipeline growth.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample

 

 

Pharmalink AB is using TARGIT drug delivery technology platform for the development of Budesonide for IgA nephropathy. The TARGIT technology is based on the application of a combination of enteric polymers onto injection-moulded starch capsules, for the targeted delivery of drugs to specific regions of the large intestine.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=iga-nephropathy-pipeline-analysis

 

The research finds that different companies have collaborated for the development of IgA nephropathy pipeline. In October 2012, Pharmalink AB entered into a contract with Patheon Inc. for manufacturing of Nefecon.

Some of the key players developing drugs for IgA nephropathy include Mallinckrodt plc, Merck KGaA, Anthera Pharmaceuticals, Inc. and others.

IgA Nephropathy Pipeline Analysis

  • By Phase
  • By Route of Administration
  • By Target
  • By Company

 

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

]]>
IgA Nephropathy Pipeline to Witness Various Collaborations in the Coming Years Mon, 15 Jan 2018 19:06:07 +0100 http://comunicati.net/comunicati/aziende/tecnologia/466032.html http://comunicati.net/comunicati/aziende/tecnologia/466032.html P&S research market P&S research market The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates in different stages of development. IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when IgA antibody gets settled in the kidneys. This leads to inflammation that with time hinders the kidney’s ability to filter wastes from blood.

 

IgA nephropathy is a silent disease in its early stages with no symptoms. But the most common symptoms that are usually observed are proteinuria and hematuria. IgA nephropathy does not have a specific treatment, and the only treatment available is to delay or prevent end stage renal disease (ESRD). Therefore, combination therapies are being used to slow down the rate of proteinuria and hematuria and the use of various targets including a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS) is expected to provide an effective and concrete treatment for the disease, with latest technological advancements further adding to the pipeline growth.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample

 

 

Pharmalink AB is using TARGIT drug delivery technology platform for the development of Budesonide for IgA nephropathy. The TARGIT technology is based on the application of a combination of enteric polymers onto injection-moulded starch capsules, for the targeted delivery of drugs to specific regions of the large intestine.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=iga-nephropathy-pipeline-analysis

 

The research finds that different companies have collaborated for the development of IgA nephropathy pipeline. In October 2012, Pharmalink AB entered into a contract with Patheon Inc. for manufacturing of Nefecon.

Some of the key players developing drugs for IgA nephropathy include Mallinckrodt plc, Merck KGaA, Anthera Pharmaceuticals, Inc. and others.

IgA Nephropathy Pipeline Analysis

  • By Phase
  • By Route of Administration
  • By Target
  • By Company

 

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

]]>
Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline: Drug Profile, Top Industry Intelligence and Therapeutic Development Mon, 15 Jan 2018 19:04:13 +0100 http://comunicati.net/comunicati/aziende/tecnologia/466031.html http://comunicati.net/comunicati/aziende/tecnologia/466031.html P&S research market P&S research market IL-6 inhibitors currently exhibits a growing pipeline with approximately 18 active drug candidates, P&S Market Research

The study analyzed that the IL-6 inhibitors therapeutics pipeline comprises approximately 18 active drug candidates in different stages of development. Interleukin-6 inhibitors acts on the IL-6 receptor. IL-6 receptors belong to a group of cytokine receptors that are expressed by leukocytes and plays an important role in the functioning of the immune system. It has a characteristic role in systemic inflammation in numerous disease conditions, including rheumatoid arthritis, and psoriatic arthritis.

 

Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/interleukin-6-inhibitors-therapeutics-pipeline

 

 

According to the research findings, most of the drug candidates of the IL-16 inhibitors are being developed as the monoclonal antibody.

The positive clinical results from IL-6 inhibitors drug candidates have been driving the pipeline growth. GlaxoSmithKline plc presented results from two pivotal Phase III studies (NCT01606761; NCT02019472) evaluating subcutaneous sirukumab. In both the studies, sirukumab met the primary endpoint showing significant improvement in the signs and symptoms of moderately to severely active rheumatoid arthritis compared to placebo.

 

Download Report Sample Copy at: https://www.psmarketresearch.com/market-analysis/interleukin-6-inhibitors-therapeutics-pipeline/report-sample

 

In January 2017, Tiziana Life Sciences plc acquired an exclusive world-wide license for NI-1201, a fully human anti-IL-6R monoclonal antibody (mAb), from Novimmune SA. In exchange for the exclusive license from Novimmune SA, Tiziana Life Sciences plc agreed to an upfront cash payment, milestone payments, and a royalty on future sales.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=interleukin-6-inhibitors-therapeutics-pipeline

 

Some of the key players developing drugs for the treatment of IL-6 inhibitors therapeutics include GlaxoSmithKline plc, Chugai Pharmaceutical Co., Ltd., Vitaeris Inc. and others.

IL-6 Inhibitors Therapeutics Pipeline Analysis

·          By Phase

·         By Molecule Type

·         By Route of Administration

·         By Company

 

 

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

 

Connect with us: LinkedIn | Twitter | Google + | Facebook

]]>
Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline: Drug Profile, Top Industry Intelligence and Therapeutic Development Mon, 15 Jan 2018 19:04:05 +0100 http://comunicati.net/comunicati/aziende/tecnologia/466030.html http://comunicati.net/comunicati/aziende/tecnologia/466030.html P&S research market P&S research market IL-6 inhibitors currently exhibits a growing pipeline with approximately 18 active drug candidates, P&S Market Research

The study analyzed that the IL-6 inhibitors therapeutics pipeline comprises approximately 18 active drug candidates in different stages of development. Interleukin-6 inhibitors acts on the IL-6 receptor. IL-6 receptors belong to a group of cytokine receptors that are expressed by leukocytes and plays an important role in the functioning of the immune system. It has a characteristic role in systemic inflammation in numerous disease conditions, including rheumatoid arthritis, and psoriatic arthritis.

 

Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/interleukin-6-inhibitors-therapeutics-pipeline

 

 

According to the research findings, most of the drug candidates of the IL-16 inhibitors are being developed as the monoclonal antibody.

The positive clinical results from IL-6 inhibitors drug candidates have been driving the pipeline growth. GlaxoSmithKline plc presented results from two pivotal Phase III studies (NCT01606761; NCT02019472) evaluating subcutaneous sirukumab. In both the studies, sirukumab met the primary endpoint showing significant improvement in the signs and symptoms of moderately to severely active rheumatoid arthritis compared to placebo.

 

Download Report Sample Copy at: https://www.psmarketresearch.com/market-analysis/interleukin-6-inhibitors-therapeutics-pipeline/report-sample

 

In January 2017, Tiziana Life Sciences plc acquired an exclusive world-wide license for NI-1201, a fully human anti-IL-6R monoclonal antibody (mAb), from Novimmune SA. In exchange for the exclusive license from Novimmune SA, Tiziana Life Sciences plc agreed to an upfront cash payment, milestone payments, and a royalty on future sales.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=interleukin-6-inhibitors-therapeutics-pipeline

 

Some of the key players developing drugs for the treatment of IL-6 inhibitors therapeutics include GlaxoSmithKline plc, Chugai Pharmaceutical Co., Ltd., Vitaeris Inc. and others.

IL-6 Inhibitors Therapeutics Pipeline Analysis

·          By Phase

·         By Molecule Type

·         By Route of Administration

·         By Company

 

 

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

 

Connect with us: LinkedIn | Twitter | Google + | Facebook

]]>
Shrink Packaging Market Research, Analysis, Trend - Forecast to 2023 Mon, 15 Jan 2018 11:54:04 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465993.html http://comunicati.net/comunicati/aziende/tecnologia/465993.html Monica Nerkar Monica Nerkar Global Shrink Packaging Market Information Report by Material (Linear Low Density Polyethylene (LLDPE), Low Density Polyethylene (LDPE), Poly vinyl chloride (PVC) and others), by Product (Hoods, Labels & Sleeves, Wrap, and Other), by Application (Food Packaging, Beverages, Paper & Textile Products, and Others) and By Region - Forecast To 2023

Global Shrink Packaging Market is expected to grow at a CAGR of 4.8% during the forecast period

Market Scenario

On the basis of regions, global shrink packaging market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). Asia-Pacific dominates the global shrink packaging market. It is expected to be the fastest growing region for the market. Rapid growth in food and beverage industry in this region driving the growth of the market. Increasing demand for consumer goods in the region mainly due to high population is also fuelling the growth of the market. Additionally, availability of raw materials and low labor cost are the factors have the positive influence on the growth of the market. North America is also expected to contribute significantly during the forecast period. Increased consumption of beverages fuelling the growth of the market.

Global shrink packaging market has been segmented based on material, product, application and region. On the basis of material, the market is segmented as Linear Low Density Polyethylene (LLDPE), Low Density Polyethylene (LDPE), Poly vinyl chloride (PVC). Low Density Polyethylene dominates the material segment of the market. Majority of shrink film is LDPE. LLDPE is expected to be the fastest growing material segment. PVC is a dense material. It is considered to be a common material in India, when clarity is an important selection criterion, particularly for consumer packaging. This is because it is relatively strong, inexpensive and has a good shrink ratio. Based on product, shrink film hoods are expected to register highest growth rate. The growth is expected to be driven by increasing demand for hoods in industrial packaging and consumer goods packaging. On the basis of applications, the market is segmented as food packaging, beverages, paper & textile products, and others. Beverages segment dominates the application segment of the market. Increased consumption of beverages across the globe driving the demand of beverages.

Shrink packaging is the process in which sheets of transparent plastic film are wrapped around a product to form a solid, weather-resistant packaging layer.

Market Highlights

Growing demand for packaged and processed food across the globe driving the growth of the market. Shrink packaging is the process in which sheets of transparent plastic film are wrapped around a product to form a solid, weather-resistant packaging layer. This packaging is transparent, making it suitable for retail and wholesale display, and ideal for general marketing purposes due to its clear surface. These are the factors also impact positively on the growth of the market. However, stringent government regulation may hamper the growth of the market

Market Research Analysis

Global shrink packaging market has been segmented based on material, product, application and region. On the basis of material, the market is segmented as Linear Low Density Polyethylene (LLDPE), Low Density Polyethylene (LDPE), Poly vinyl chloride (PVC). Low Density Polyethylene dominates the material segment of the market. Majority of shrink film is LDPE. LLDPE is expected to be the fastest growing material segment. PVC is a dense material. It is considered to be a common material in India, when clarity is an important selection criterion, particularly for consumer packaging. This is because it is relatively strong, inexpensive and has a good shrink ratio.

Based on product, shrink film hoods are expected to register highest growth rate. The growth is expected to be driven by increasing demand for hoods in industrial packaging and consumer goods packaging. On the basis of applications, the market is segmented as food packaging, beverages, paper & textile products, and others. Beverages segment dominates the application segment of the market. Increased consumption of beverages across the globe driving the demand of beverages.

Asia-Pacific region dominates the global shrink packaging market

On the basis of regions, global shrink packaging market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). Asia-Pacific dominates the global shrink packaging market. It is expected to be the fastest growing region for the market. Rapid growth in food and beverage industry in this region driving the growth of the market. Increasing demand for consumer goods in the region mainly due to high population is also fuelling the growth of the market. Additionally, availability of raw materials and low labor cost are the factors have the positive influence on the growth of the market.

North America is also expected to contribute significantly during the forecast period. Increased consumption of beverages fuelling the growth of the market.

The report for Global Shrink Packaging Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.

Access Full Report @ https://www.marketresearchfuture.com/reports/shrink-packaging-market-4264

]]>
Plastic Packaging Industry Analysis and Foresight Report to 2022 Mon, 15 Jan 2018 11:41:34 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465991.html http://comunicati.net/comunicati/aziende/tecnologia/465991.html Monica Nerkar Monica Nerkar Plastic Packaging Market Information by Type (Rigid packaging and Flexible packaging) by Application (Food & beverages, Industrial, Healthcare, Personal care, and others) and by Region - Forecast to 2022

Market Scenario

The market for plastic packaging is driven by growth in food & beverages and healthcare industries globally. The change in consumer’s lifestyle with rapid urbanization has augmented the demand for plastic packaging. The consumers demand convenience processed and packaged foods which reduce the cooking time. This has resulted in increasing use of plastic packaging in food & beverage industries. Food & beverage was valued as the largest application for plastic packaging market in 2015. Over 54% of the volume consumption in 2015 was attributed to the food & beverage industry. It is expected to show far reaching results by 2022 in the APAC region. Furthermore the increasing health risks and growing health and fitness awareness has further fueled the market for plastic packaging. The global plastic packaging market is expected to cross USD 400 Billion at the end of the forecasted period and is expected to grow at CAGR of approximately 5% from 2016 to 2022.

Regional Analysis of Global Packaging Machinery Market

APAC dominates the global plastic packaging market with its fast growing market worldwide. Over 35% of total volume consumption in 2015 was valued for APAC region. The region is expected to show some rapid development in healthcare and food & beverages industries along with increased investment in the same. This would result in an expanding share of APAC in global plastic packaging market by 2022.

However, North America had the largest market size in 2015 and is expected to show steady growth by 2022. Europe and Rest of the World are also expected to grow from 2016 to 2022. The food and beverage market in Europe is expected to show some staggering growth which is expected to drive the plastic packaging market by 2022.

Key Players

The key players of Global Plastic Packaging Market report include- Amcor Ltd, BASF SE, Crown Holdings Inc., Saint-Gobain, Bemis Company Inc., Huhtamaki Oyj, Mondi Group, Sealed Air Corporation, Sonoco Products Company, Constantia Flexibles International GmbH, Ampac Holdings LLC and Wipak Group.

 

Access Full Report@ https://www.marketresearchfuture.com/reports/plastic-packaging-market-1688    

]]>
Pressure Sensitive Tapes Market Attracts Investor Interest with Unparalleled Growth Rates Mon, 15 Jan 2018 11:25:42 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465989.html http://comunicati.net/comunicati/aziende/tecnologia/465989.html Monica Nerkar Monica Nerkar Global Pressure Sensitive Tapes Market Information by Backing Material (Paper, PVC, Polypropylene, and others) by Product (Masking, Carton Sealing, Electrical, Double-sided, and others) by Application (Healthcare, Packaging, Construction, Manufacturing, and others) and Region - Forecast to 2022 

Pressure Sensitive Tapes Market– Overview 

As pressure sensitive tapes do not require water or any other solvents for adhesion purposes and are convenient to use, the market for this product category it growing at an accelerated pace. Market Research Future, a firm which specializes in market reports related to the Packaging & Transport sector recently published in its report on ‘Global Pressure Sensitive Tapes Market Research Report - Forecast to 2022’ that the segment will witness more than average revenue levels in USD million at the end of the forecasted period and is expected to grow at a remarkable CAGR % from 2016 to 2022. 

Since the inception of pressure sensitive tapes, they have found applications in many sectors and for various purposes. The versatility of this product has enabled the gradual growth in demand observed in the market. Since the advent of these types of tapes, they are increasingly replacing the use of screws, nuts and bolts in mechanical operations. Pressure sensitive tapes are also finding startling applications in the medical and healthcare sector which is further spurring the demand for this segment. The amount of orthopedic injuries and stable improvements in surgical procedures have further prompted the growth trend in this sector. Rise in the market for effective packing solutions that are not only effective but also cost efficient has further prompted the growth of this sector. With different requirements arising on a regular basis, the product types and qualities are also undergoing evolution. 

Expanding uses of electronics in the automotive have also additionally boosted the adhesive tape market. With emphasis increasingly being on environmental friendly packaging increasing worldwide, the pressure sensitive tapes are also being manufactured with the special quality so as to enable them to decompose easily once they have satisfied their use. High demand for pressure sensitive tapes is on the rise, especially in emerging economies in the APAC region. Markets such as Malaysia and Indonesia are actively promoting the use of for pressure sensitive tapes in their healthcare sector and medical sectors. The pressure sensitive tapes market can however find its growth hampered due to increase in the cost of raw materials in the world and high levels of manufacturing costs. 

Latest Industry Updates: 

Nov 2017 Lincoln International, a leading global mid-market investment bank has announced that Wingate Partners have sold Nekoosa to Sentinel Capital Partners. The Company produces a comprehensive suite of materials in four key product areas: application and pressure sensitive tapes used to protect and transfer graphics onto surfaces among other possible applications. 

May 2017 Avery Dennison Corp. of Glendale announced lately that it had acquired Finesse Medical, an Irish medical supply manufacturer, for an undisclosed amount. Finesse Medical generated more than 15 million euros in revenue last year. Finesse Medical was acquired to strategically pair with Avery Dennison’s subsidiary Vancive Medical Technologies, a manufacturer of medical tapes. 

July 2017 Intertape Polymer Group Inc. announced the completion on July 1 of the previously-announced transaction to acquire substantially all of the assets of Canadian Technical Tape Ltd., a North American supplier of industrial and specialty tapes based in Montreal. 

Feb 2017 California-based label and packaging company Avery Dennison has agreed to acquire China-based Yongle Tape Co. for total consideration of up to $245 million. Yongle is a prominent manufacturer of PVC tapes and pressure-sensitive harnessing for the automotive, electrical and communications industries. 

Pressure Sensitive Tapes Market- Competitive Analysis

With the entry of industry players in pressure sensitive tapes segment, a trend of solid, volume-driven growth has been observed in the market with the development of different varieties of product types. With companies aiming to capture a considerable share of the market segment as early as possible, they are competing and experimenting with various advantage points. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the optimal strategies.

The key players of global pressure sensitive tapes market report include Avery Dennison Corporation, 3M Company, Berry Plastics Corporation, American Biltrite Inc., Jonson Tapes Limited, Adchem Corporation, Nitto Denko Corporation. Some of the other important players in the market are Intertape Polymer Group, Advance Tapes International Limited, Tesa SE, LINTEC Corporation, Scapa Group, Shurtape Technologies, LLC and Zhejiang Yonghe Adhesive Products Company Limited.

Pressure Sensitive Tapes Market– Segments

The pressure sensitive tapes market has been divided on the basis of backing materials, products, application and region.

On The Basis Of Backing Material: Paper, PVC, Polypropylene, and others

On The Basis Of Product: Masking, Carton Sealing, Electrical, Double-sided, and others

On The Basis Of Application: Healthcare, Packaging, Construction, Manufacturing, and others

On The Basis Of Region: North America, Europe, Asia Pacific and ROW.

Pressure Sensitive Tapes Market- Regional Analysis

The global pressure sensitive tapes market is segmented into North America, Europe, APAC, and Rest of the World (RoW). APAC dominates the global pressure sensitive tapes market with its fastest growing market worldwide. It will expand at a stellar CAGR over the forecast period. The region is expected to show rapid growth in healthcare and construction sectors leading to a fast growing pressure sensitive tapes market. The increased government initiatives to improve medical & healthcare sector further fuels this market.

However, North America holds an impressive market share of pressure sensitive market and is expected to grow rapidly by 2022. It is followed by Europe which is also expected to grow at an encouraging CAGR respectively from 2016 to 2022.

Access Full Report @ https://www.marketresearchfuture.com/reports/pressure-sensitive-tapes-market-1620

]]>
Best deals of Samsung Galaxy Note 8 in 2018 Sat, 13 Jan 2018 04:01:20 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465769.html http://comunicati.net/comunicati/aziende/tecnologia/465769.html iPhone parts iPhone parts The Samsung Galaxy Note 8 certainly has a point to prove and it's now available buy. It's never going to be your go-to option if you're on a tight budget, but it's got the screen size and specification smarts to be a competitor to the much lauded iPhone 6s parts .

The price fell drastically for Black Friday and it seemed to sell by the bucket-load. Luckily, prices have remained pretty low since, so there are still some great Note 8 deals to be found. Check out our price comparison tool below for the best prices. We've picked out five of our favourite deals as well, and we tell you more about this mammoth mobile further down the page.

It might seem a tad unfair, but we can't not mention the Galaxy Note 7 debacle when talking about its successor. Samsung's 2016 aborted project due to overheating and fire risks means that we've had to wait two years for a fully functioning Note-branded phablet from the South Korean tech behemoth. But we can now move forward from that chapter in tech history - the Note 8 is well and truly here!

Samsung Galaxy Note 8 review and key specifications

Wondering what all the fuss is about? Well the fervour for the Note 8 is probably doubled due to the fact that the Note 7 was pulled from shelves soon after release. But it doesn't take more than one look at the iPhone 6s spare parts to see that it justifies the hype.

 

The huge 6.3-inch ‘Infinity Display,’ is gorgeous to look at, the 6GB RAM innards go like a train and there are two best-in-class rear cameras. It's expensive, but we think the Note 8 is worth it.

]]>
Europe Sleep Apnea Devices Market Fri, 12 Jan 2018 15:06:08 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465719.html http://comunicati.net/comunicati/aziende/tecnologia/465719.html Research Cosmos Research Cosmos In this region, the Europe Sleep Apnea Devices Market is expected to reach USD 2,172.7 million by 2024, from USD 3,834.5 million in 2016 growing at to CAGR of 6.5% in the forecast period of 2017 to 2024.

 

Based on geography, the Europe sleep apnea devices market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-sleep-apnea-devices-market-analysis-industry-outlook-and-forecast-2017-to-2024/1635171675

 

Europe sleep apnea devices market competition by top players

Koninklijke Philips N.V. dominated the sleep apnea devices market in 2016, followed by Natus Medical Incorporated, and Nihon Kohden along with others such as

CareFusion Corporation,

Curative Medical Inc.,

ResMed,

Fisher and Paykel Healthcare Limited.,

SomnoMed,

BMC Medical Co., Ltd.,

Compumedics Limited,

NatusMedical Inc.,

DeVilbiss Healthcare,

Global Medical Holdings,

Itamar Medical Ltd.,

Weinmann Medical Technology,

Cleveland Medical Devices Inc.,

SOMNOmedics GmbH,

Deymed Diagnostic,

NovaSom,

Medtronic.

 

Request free sample @ https://www.researchcosmos.com/request/1635171675

 

The Europe sleep apnea device market is segmented on the basis of product type, end user and geography.

 

On the basis of type, sleep apnea device market is categorized into: diagnostic devices and therapeutic devices.

 

On the basis of product type, the diagnostic sleep apnea device market is segmented into polysomnography devices, respiratory polygraphs, pulse oximeters and actigraph systems.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1635171675

 

On the basis of product type, the therapeutic sleep apnea devices are segmented into positive airway pressure devices (PAP), continuous positive airway pressure devices (CPAP), automatically adjusting positive airway pressure devices (APAP), masks, adaptive servo ventilation, airway clearance system, oxygen concentrators, oral appliances and accessories.

 

On the basis of end users, the Europe sleep apnea devices market is further segmented into hospitals, sleep clinics, community healthcare and home healthcare. In 2017, the hospitals segment dominates the global sleep apnea device market. 

 

Check for discount @ https://www.researchcosmos.com/discount/1635171675  

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the globe. We are associated with world renowned publishers who when combined, serve hundreds of companies that publish and cover a wide range of insights.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line : +1 888 709 8757

Mail: dani@researchcosmos.com

 

www.researchcosmos.com

]]>
Europe Radiotherapy Market Fri, 12 Jan 2018 15:05:34 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465717.html http://comunicati.net/comunicati/aziende/tecnologia/465717.html Research Cosmos Research Cosmos In this region, The Europe Radiotherapy Market is projected to reach USD 2,572.3 million by 2024, from USD 1,487.1 million in 2016 growing at to CAGR of 7.1% in the forecast period 2017 to 2024

 

Based on geography, the Europe radiotherapy analyzers is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-radiotherapy-market-analysis-industry-outlook-and-forecast-2017-to-2024/1035751431

 

Europe radiotherapy market competition by top players

Varian Medical Systems, Inc. dominated the radiotherapy market followed by Elekta AB, and Accuray, Inc. along with others

CIVCO Medical Solutions,

Brainlab AG,

C. R. Bard, Inc.,

IsoRay Medical, Inc.,

Nordion, Inc.,

RaySearch Laboratories AB,

PRECISIS AG,

Mevion Medical Systems, Inc.,

TechnicasRadiofiscas S.L.,

Hitachi, Ltd.,

Sumitomo Heavy Industries, Ltd.,

Mitsubishi Electric Corporation,

ProNova Solutions, LLC,

ProTom International

 

Request free sample @ https://www.researchcosmos.com/request/1035751431

 

The Europe radiotherapy market is segmented on the basis of type, product type, indication, and geography.

 

The Europe radiotherapy market is segmented into three types, namely beam radiotherapy, brachytherapy and systematic radiotherapy.

 

Radiotherapy market is segmented into beam radiotherapy, brachytherapy and systematic radiotherapy.

 

The beam radiotherapy is segmented into IGRT, IMRT, VMAT, tomotherapy, stereotactic technology and 3D conformal technology.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1035751431

 

The brachytherapy is segmented into LDR and HDR.

 

On the basis of product type, the market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy softwares and systematic radiotherapy.

 

External beam radiotherapy is segmented into LINAC, CyberKnife, proton therapy and Gamma Knife.

 

The proton beam is segmented into cyclotron and synclotron. The internal beam is segmented into seeds and afterloaders.

 

Check for discount @ https://www.researchcosmos.com/discount/1035751431

 

The radiotherapy softwares is segmented into treatment planning softwares, dosage planning softwares, patient positioning softwares and image guiding softwares.

 

On the basis of indication, the market is segmented into prostate cancer, breast cancer, lung cancer, spine cancer, liver cancer, brain cancer and others.  

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the globe. We are associated with world renowned publishers who when combined, serve hundreds of companies that publish and cover a wide range of insights.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line : +1 888 709 8757

Mail: dani@researchcosmos.com  

 

www.researchcosmos.com

]]>
Europe Nerve Repair Biomaterials Market Fri, 12 Jan 2018 15:04:51 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465715.html http://comunicati.net/comunicati/aziende/tecnologia/465715.html Research Cosmos Research Cosmos In this region, Europe Nerve Repair Biomaterials Market is projected to reach USD 191.88 million by 2024, from USD 98.99 million in 2016 growing at a CAGR of 9.9% in the forecast period 2017 to 2024.

 

Based on geography, the Europe nerve repair biomaterials market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-nerve-repair-biomaterials-market-analysis-industry-outlook-and-forecast-2017-to-2024/414830755

 

Europe nerve repair biomaterials market competition by top players including -

Integra Life Sciences is going to dominate the nerve repair biomaterials market followed by Stryker Corporation and Collagen Matrix, Inc. along with others such as

AxoGen, Inc.,

Checkpoint Surgical, Inc.,

Polyganics,

Synovis Micro Companies Alliance, Inc.

 

Request free sample @ https://www.researchcosmos.com/request/414830755

 

Based on product type, the global nerve repair biomaterials market is segmented into nerve repair and nerve protection.

 

The global nerve repair biomaterials market is further segmented into nerve conduits and nerve grafts.

 

Nerve repair graft is further segmented into allograft and acellularized allograft. Nerve protection market is segmented into nerve protector and nerve wrap.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/414830755

 

Based on the injury type, the nerve repair biomaterials market is segmented into epineural nerve repair, perineural nerve repair, and group fascicular repair.

 

On the basis of end user, the global nerve repair biomaterials market is categorized into hospitals, clinics, and ambulatory surgical centres.

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line: +1 888 709 8757

Mail: dani@researchcosmos.com

 

www.researchcosmos.com

]]>
Europe Medical Nonwovens Market Fri, 12 Jan 2018 15:04:16 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465714.html http://comunicati.net/comunicati/aziende/tecnologia/465714.html Research Cosmos Research Cosmos In this region, The Europe Medical Nonwovens Market is projected to reach USD 2,756.6 million by 2024, from USD 2,046.7 million in 2016 growing at a CAGR of 3.8% in the forecast period 2017 to 2024.

 

Based on geography, the Europe medical nonwovens market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-medical-nonwovens-market-analysis-industry-outlook-and-forecast-2017-to-2024/1359910841

 

Europe medical nonwovens market competition by top players including -

Berry Plastics Group, Inc. is going to dominate the medical nonwovens market followed with Halyard Health, Inc., and Fraudenberg Performance Material, along with others such as

Avgol Ltd.,

Fibertex Non Wovens A/S and Pegas Nonwovens,

3M,

KCWW,

Halyard Health, Inc.,

Advanced Fabrics (SAAF),

Biovation LLC,

Intco Medical,

Ahlstrom Corporation,

Ansell Healthcare,

Asahi Kasei Corporation,

Cypress Medical Products,

Dynarex Corporation,

Georgia-Pacific,

Hogy Medical,

Molnlycke Health Care AB,

Paul Hartmann AG,

Precision Fabrics Group, Inc.,

Domtar Corporation,

Cardinal Health,

UniCharm Corporation,

Kraton Performance Polymers Inc.,

Medline Industries, Inc.

 

Request free sample @ https://www.researchcosmos.com/request/1359910841

 

The Europe medical nonwovens market is segmented on the basis of type, product type, usability, end user, distribution channel and geography.

 

On the basis of type, medical nonwovens are categorized into spunbond, meltblown, drylaid, wetlaid and spun-melt-spun (SMS).

 

On the basis of product type, the medical nonwovens market is segmented into hygiene and apparel products.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1359910841

 

On the basis of product type, hygiene is sub-segmented into incontinence pads, ostomy liners, disposable underwear’s, CSR wraps, disposable medical wipes and diapers.

 

Apparel products are sub-segmented into surgical masks, surgical packs, surgical drapes and gowns, surgical caps and wound care material.

 

On the basis of end-user, this market is segmented into hospitals, clinics, home healthcare, laboratories and ambulatory surgical centers.

 

Check for discount @ https://www.researchcosmos.com/discount/1359910841

 

On the basis of distribution channel, the Europe medical nonwovens market is segmented into direct tenders and retail

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line: +1 888 709 8757

Mail: dani@researchcosmos.com

 

www.researchcosmos.com

]]>
Europe IUCD Devices Market Fri, 12 Jan 2018 15:03:32 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465713.html http://comunicati.net/comunicati/aziende/tecnologia/465713.html Research Cosmos Research Cosmos In this region, Europe IUCD Devices Market is projected to reach USD 757.5 million by 2024, from USD 561.7 million in 2016 growing at a CAGR of 3.9% in the forecast period 2017 to 2024

 

Based on geography, the Europe IUCD devices market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-intra-uterine-contraceptive-devices-market-analysis-industry-outlook-and-forecast-2017-to-2/1457411170

 

Europe IUCD devices market competition by top players including –

Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include

DKT International,

Egemen International,

Melbea AG,

Ocon Medical Ltd.,

Pregna International Limited,

Medical Engineering Corporation SA ,

SMB Corporation and Meril Life Sciences Pvt. Ltd.,

Medu Scientific Ltd, China RH Contraceptives Co., Ltd,

Sanghai Jolly Medical Education Co., Ltd,

Bernstein Leibhard LLP,

Zheijang Daji Medical Instruments, Ltd.,

Nimble International,

AME Line, Technico,

Cepeo,

Contraceptivos,

Injeflex Ind and Com Ltda,

Bersil,

Amed.

 

Request free sample @ https://www.researchcosmos.com/request/1457411170

 

The Europe intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

 

The Europe intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1457411170

 

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

 

Check for discount @ https://www.researchcosmos.com/discount/1457411170

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line: +1 888 709 8757

Mail: dani@researchcosmos.com

 

www.researchcosmos.com

]]>
Europe Hemostats Market Fri, 12 Jan 2018 15:02:11 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465712.html http://comunicati.net/comunicati/aziende/tecnologia/465712.html Research Cosmos Research Cosmos In this region, Europe Hemostats Market is projected to reach USD 1,093.7 million by 2024, from USD 641.6 million in 2016 growing at to CAGR of 6.9% in the forecast period 2017 to 2024.

 

Based on geography, the Europe hemostats market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-hemostats-market-analysis-industry-outlook-and-forecast-2017-to-2024/791251161

 

Europe hemostats market competition by top players

Ethicon US LLC (US) is dominating the hemostats market followed by Pfizer and CR Bard Inc.

Baxter,

Vascular Solutions, Inc.,

B.Braun Melsungen,

3-D Matrix, Ltd.,

Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company),

Anika Therapeutics, Inc.,

Arch Therapeutics Inc.,

Biom’Up SAS,

CryoLife, Inc.,

Gamma Therapeutics, Inc.,

Hemostasis, LLC,

MedTrade Products Limited, I

ntegra LifeSciences Corporation,

Medline Industries, Inc.,

HEMOTEC MEDICAL GMBH,

Stryker,

CSL Behring,

Mallinckrodt,

Equimedical, B.V.

Request free sample @ https://www.researchcosmos.com/request/791251161

 

The Europe hemostats market is segmented on the basis of type, application, distribution channel, and end user.

 

The Europe hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/791251161  

 

On the basis of application, the market is segmented into surgery and wound closure.

 

On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centers and clinics.

 

Check for discount @ https://www.researchcosmos.com/discount/791251161

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the globe. We are associated with world renowned publishers who when combined, serve hundreds of companies that publish and cover a wide range of insights.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line : +1 888 709 8757

Mail: dani@researchcosmos.com

www.researchcosmos.com

 

 

]]>
Commercial Robotic Cleaners Fri, 12 Jan 2018 15:01:47 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465711.html http://comunicati.net/comunicati/aziende/tecnologia/465711.html Research Cosmos Research Cosmos Robotic cleaning technology has been advancing and transforming the cleaning landscape in commercial settings. An increasing shipment of cleaning robots has been observed in global market because these smart equipment’s can lower labor cost, improve cleaning efficiency, and reduce working accidents. Industrial and commercial robotic cleaners are expected to gain momentum in professional cleaning required by manufacturing plants, healthcare facilities, education buildings, retails, logistics, business centers, etc. Global total revenue of will advance to $XXX million in 2023, registering a CAGR of XX% between 2016 and 2023. This represents a cumulative revenue of $7.806 billion during 2017-2023 owing to a fast-growing adoption of robotic solutions for cleaning floors, pools, windows, gutters, ducks/pipes, storage tanks and boilers, and hulls across a magnitude of commercial sectors.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/commercial-robotic-cleaners/1547739203

 

Highlighted with 27 tables and 57 figures, this 136-page report “Commercial Robotic Cleaners: Global Market 2017-2023 by Vertical, Application and Region” is based on a comprehensive research of worldwide commercial robotic cleaner market by analyzing the entire global market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2014 and 2015, revenue estimates for 2016, and forecasts from 2017 till 2023.

 

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

 

Request free sample @ https://www.researchcosmos.com/request/1547739203

 

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global commercial cleaning robots market in every aspect of the classification from perspectives of vertical, application, and region.

 

Based on vertical, the global market is segmented into the following sub-markets with annual revenue included for 2014-2023 (historical and forecast) for each section.

• Industry and Manufacture (divided by the following applications)

·         Floor Cleaning

·         Tube and Pipe Cleaning

·         Storage Tank and Boiler

·         Hull Cleaning

·         Window Cleaning

·         Other Cleaning

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1547739203

 

• Healthcare (segmented based on the following applications)

·         Floor Cleaning

·         Pool Cleaning

·         Window Cleaning

·         Other Cleaning

• Business (categorized based on the following categories)

·         Floor Cleaning

·         Window Cleaning

·         Other Cleaning

• Logistics (analyzed according to the following segments)

·         Floor Cleaning

·         Window Cleaning

·         Wall Cleaning

·         Other Cleaning

• Other Commercial Sectors

 

Geographically, the following regions together with the listed national markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC)

• Europe (Germany, France, UK, Italy, Spain, Rest of Europe)

• North America (U.S. and Canada)

• Latin America

• RoW

 

Check for discount @ https://www.researchcosmos.com/discount/1547739203

 

For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2014-2023. The breakdown of all regional markets by country and split of some key national markets by vertical over the forecast years are also included.

 

The report also covers current competitive scenario and the predicted manufacture trend; and profiles global commercial robotic cleaner vendors including market leaders and important emerging players.

 

GMD's Risk Assessment System. Specifically, potential risks associated with investing in the global market. Critical Success Factors (CSFs) are generated as a guidance to help investors and stockholders manage and minimize the risks, develop appropriate business models, and make strategies and decisions.

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the globe. We are associated with world renowned publishers who when combined, serve hundreds of companies that publish and cover a wide range of insights.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line : +1 888 709 8757

Mail: dani@researchcosmos.com  

 

www.researchcosmos.com

]]>
Global Pool Cleaning Robots Market Fri, 12 Jan 2018 15:01:14 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465710.html http://comunicati.net/comunicati/aziende/tecnologia/465710.html Research Cosmos Research Cosmos Robotic cleaning technology has been evolving and transforming the pool into both residential and commercial settings. Penetration rate of pool cleaning has been largely improved across the world because these robotic pool cleaners can save time and improve efficiency. Cumulative revenue of $ 3.79 billion during 2017-2023 owing to a fast-growing adoption of robots for the global total revenue of pool cleaning robots will advance to $ XXX million in 2023, growing at a CAGR of 20% between 2016 and 2023. cleaning pools.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/global-pool-cleaning-robots-market-2017-2023/208176880

 

Highlighted with 20 tables and 57 figures, this 120-page report “Global Pool Cleaning Robots Market 2017-2023 by Application, Drive Mechanism and Region: Segment Analysis, Trend Outlook and Business Strategy” is based on a comprehensive research of worldwide robotic pool cleaner market by analyzing the entire global market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2014 and 2015, revenue estimates for 2016, and forecasts from 2017 till 2023.

 

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

 

Request free sample @ https://www.researchcosmos.com/request/208176880

 

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global cleaning robots market in every aspect of the classification from perspectives of application, drive mechanism and region.

 

Based on application, the global market is segmented into the following sub-markets with annual revenue included for 2014-2023 (historical and forecast) for each section.

• Residential Application

• Commercial Application

 

On basis of drive mechanism, the global market is analyzed on the following segments with annual revenue in 2014-2023 provided for each segment.

• Suction-side Pool Cleaners

• Pressure-side Pool Cleaners

• Electric Pool Cleaners

 

Inquire before buying @ https://www.researchcosmos.com/inquire/208176880

 

Geographically, the following regions together with the listed national markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC)

• Europe (Germany, France, UK, Italy, Spain, Rest of Europe)

• North America (U.S. and Canada)

• Latin America

• RoW

 

For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2014-2023. The breakdown of all regional markets by country and split of some key national markets by robot application over the forecast years are also included.

 

Check for discount @ https://www.researchcosmos.com/discount/208176880

 

In addition, the report covers current competitive scenario and the predicted manufacture trend; and profiles global pool cleaning robot vendors including market leaders and important emerging players.

 

Specifically, potential risks associated with investing in global pool cleaning robots market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the globe. We are associated with world renowned publishers who when combined, serve hundreds of companies that publish and cover a wide range of insights.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line : +1 888 709 8757

Mail: dani@researchcosmos.com  

 

www.researchcosmos.com

]]>